Article Information
PubMed
Print ISSN
Online ISSN
History
- Published online December 1, 2021.
Article Versions
- You are currently viewing an Earlier version of this article (December 1, 2021 - 07:49).
- View the most recent version of this article
Copyright & Usage
© 2020 The Authors. This is an open access article under the terms of the Creative Commons Attribution CC BY License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Author Information
- Ann A Holmberg1,*,
- Lars Weidolf2,
- Sofia Necander3,
- Peter Bold4,
- Sharan Sidhu5,
- Marta Pelay-Gimeno6,
- Rianne A.F. de Ligt6,
- Elwin R Verheij6,
- Alexandra Jauhiainen7,
- Ioannis Psallidas8,
- Ulrika Wählby Hamrén9, and
- Susanne Prothon9
- 1AstraZeneca, Sweden
- 2iMed CVMD DMPK, AstraZeneca R&D Molndal, Sweden
- 3Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Sweden
- 4Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Sweden
- 5Quotient Sciences, United Kingdom
- 6TNO, Netherlands
- 7BioPharma Early Biometrics and Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Sweden
- 8Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, United Kingdom
- 9Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Science, R&D, AstraZeneca, Sweden
- ↵* Corresponding Author:
Ann A Holmberg, AstraZeneca, Gothenburg, N/A, Sweden. E-mail: Ann.AurellHolmberg1{at}astrazeneca.com